Fundraising Fox

Alife

Founded 2020 · 82 employees on LinkedIn · 6 known investors

Alife Health develops artificial intelligence technology to modernize and personalize the in vitro fertilization (IVF) process for fertility clinics and patients.

AI & Machine LearningDigital HealthHealthtechMedical Devices

Founders & leadership

Alife was founded in 2020 by Paxton Maeder-York.

PMPaxton Maeder-York
Paxton Maeder-YorkinCEO & Founder

Investors · 6

Lux Capital✓ verifiedNew York · $100K – $100M
Maveron✓ verifiedSeattle · $100K – $8M
Farvatn VentureBergen
Union Square Ventures (USV)New York City · $1M – $8M
IA VenturesreportedNew York · $1M – $3M
SpringbankreportedNew York · $500K – $1.5M

In the news

Alife launches AI technology to advance IVF treatment outcomes, lower costsfiercehealthcare.com · Oct 2022Alife Raises $22M to Advance In-Vitro Fertilization Through AI | TechTargettechtarget.com · Apr 2022Alife Announces its $22 Million Series A to Modernize and Personalize Fertility Care with Artificial Intelligenceprnewswire.com · Mar 2022Alife Health raises $22M series A for fertility AI tools | Fierce Healthcarefiercehealthcare.com · Mar 2022Alife raises $9.5M seed financing - MassDevicemassdevice.com · May 2021

Frequently asked questions

What does Alife do?
Alife Health develops artificial intelligence technology to modernize and personalize the in vitro fertilization (IVF) process for fertility clinics and patients.
Who founded Alife?
Alife was founded by Paxton Maeder-York in 2020.
Who are Alife's investors?
Alife's investors include Lux Capital, Maveron, Farvatn Venture, Union Square Ventures (USV), IA Ventures, Springbank.